Amedeo Smart

Free Medical Literature Service

 

Amedeo

Hypertension
  Free Subscription

Articles published in
Eur Heart J
    September 2024
  1. OBIEZU-UMEH C, Huffman MD, Ojji DB
    Integration of a hypertension treatment programme into Nigeria's primary healthcare system: report from a stakeholders and policymakers' workshop.
    Eur Heart J. 2024 Sep 10:ehae376. doi: 10.1093.
    >> Share

  2. VERGALLO R, Volpe M
    Weekly Journal Scan: A large Chinese SPRINT supports 'the lower, the better' blood pressure in hypertensive patients at high cardiovascular risk.
    Eur Heart J. 2024 Sep 4:ehae531. doi: 10.1093.
    >> Share

  3. COHEN JB, Bress AP
    Quantifying antihypertensive effects of GLP-1 agonists.
    Eur Heart J. 2024 Sep 1:ehae520. doi: 10.1093.
    >> Share

    August 2024
  4. MCEVOY JW, McCarthy CP, Bruno RM, Brouwers S, et al
    2024 ESC Guidelines for the management of elevated blood pressure and hypertension.
    Eur Heart J. 2024 Aug 30:ehae178. doi: 10.1093.
    >> Share

  5. CREA F
    Expanding knowledge in atrial fibrillation, blood pressure treatment, and management of coronary and peripheral artery disease.
    Eur Heart J. 2024;45:2795-2799.
    >> Share

  6. BOHM M, de la Sierra A, Mahfoud F, Schwantke I, et al
    Office measurement vs. ambulatory blood pressure monitoring: associations with mortality in patients with or without diabetes.
    Eur Heart J. 2024;45:2851-2861.
    >> Share

  7. MANCIA G, Facchetti R, Grassi G
    Risk prediction by ambulatory blood pressure monitoring in non-diabetic and diabetic patients: better than office measurements.
    Eur Heart J. 2024;45:2862-2864.
    >> Share

  8. ROSENKRANZ S, Hoeper MM, Maron BA
    Pulmonary hypertension in heart failure: the good, the bad, and the ugly.
    Eur Heart J. 2024 Aug 12:ehae518. doi: 10.1093.
    >> Share

    July 2024
  9. FAUVEL C, Damy T, Berthelot E, Bauer F, et al
    Post-capillary pulmonary hypertension in heart failure: impact of current definition in the PH-HF multicentre study.
    Eur Heart J. 2024 Jul 26:ehae467. doi: 10.1093.
    >> Share

  10. ROGER G, Ducrocq G, Mesnier J, Sayah N, et al
    Chronic coronary syndromes without standard modifiable cardiovascular risk factors and outcomes: the CLARIFY registry.
    Eur Heart J. 2024;45:2396-2406.
    >> Share

    April 2024
  11. VERGALLO R, Volpe M
    Lowering dietary sodium intake to reduce blood pressure: cum grano salis.
    Eur Heart J. 2024;45:1301-1302.
    >> Share

    March 2024
  12. PITRE T, Weatherald J, Humbert M
    Treatments for pulmonary arterial hypertension: navigating through a network of choices.
    Eur Heart J. 2024 Mar 5:ehae106. doi: 10.1093.
    >> Share

  13. MA E, Wo D, Chen J, Yan H, et al
    Inhibition of a novel Dickkopf-1-LDL receptor-related proteins 5 and 6 axis prevents diabetic cardiomyopathy in mice.
    Eur Heart J. 2024;45:688-703.
    >> Share

    February 2024
  14. MOUTCHIA J, McClelland RL, Al-Naamani N, Appleby DH, et al
    Pulmonary arterial hypertension treatment: an individual participant data network meta-analysis.
    Eur Heart J. 2024 Feb 28:ehae049. doi: 10.1093.
    >> Share

  15. RUILOPE LM, Ortiz A, Ruiz-Hurtado G
    Hypertension and the kidney: an update.
    Eur Heart J. 2024 Feb 8:ehad896. doi: 10.1093.
    >> Share

    January 2024
  16. GUPTA A, Whiteley WN, Godec T, Rostamian S, et al
    Legacy benefits of blood pressure treatment on cardiovascular events are primarily mediated by improved blood pressure variability: the ASCOT trial.
    Eur Heart J. 2024 Jan 31:ehad814. doi: 10.1093.
    >> Share

    December 2023
  17. TOTH PP
    Dickkopf-1: an emerging danger signal in hypertension and cardiovascular disease.
    Eur Heart J. 2023 Dec 29:ehad797. doi: 10.1093.
    >> Share

  18. HE Z, Zhang D, Wang X
    Fibrosing mediastinitis manifesting as refractory pleural effusion and severe pulmonary hypertension successfully treated by percutaneous pulmonary vein stenting.
    Eur Heart J. 2023 Dec 28:ehad862. doi: 10.1093.
    >> Share

  19. LI XM, Zhu XJ, Jing ZC
    Reverse cardiac remodelling after balloon atrial septostomy for pulmonary arterial hypertension and end-stage heart failure.
    Eur Heart J. 2023 Dec 16:ehad822. doi: 10.1093.
    >> Share

  20. O'DONNELL M, Yusuf S, Vogt L, Mente A, et al
    Potassium intake: the Cinderella electrolyte.
    Eur Heart J. 2023;44:4925-4934.
    >> Share

  21. SCHNEIDER SR, Muller J, Bauer M, Mayer L, et al
    Overnight exposure to high altitude in pulmonary hypertension: adverse events and effect of oxygen therapy.
    Eur Heart J. 2023 Dec 11:ehad789. doi: 10.1093.
    >> Share

    November 2023
  22. VOLPE M, Galiuto L
    More on aldosterone biosynthesis inhibition and resistant hypertension: a Phase-2 study with lorundrostat.
    Eur Heart J. 2023 Nov 9:ehad756. doi: 10.1093.
    >> Share

  23. TSCHIDERER L, van der Schouw YT, Burgess S, Bloemenkamp KW, et al
    Hypertensive disorders of pregnancy and cardiovascular disease risk: A Mendelian Randomisation study.
    Eur Heart J. 2023;44.
    >> Share

  24. GALIE N, Palazzini M, Manes A
    Confirmation of survival prediction based on 2022 ESC/ERS pulmonary hypertension guidelines new haemodynamic thresholds.
    Eur Heart J. 2023 Nov 7:ehad672. doi: 10.1093.
    >> Share

  25. ACKLAND GL, Patel A, Abbott TEF, Begum S, et al
    Discontinuation vs. continuation of renin-angiotensin system inhibition before non-cardiac surgery: the SPACE trial.
    Eur Heart J. 2023 Nov 7:ehad716. doi: 10.1093.
    >> Share

    October 2023
  26. BRAUNWALD E
    Inhibition of angiotensinogen in the treatment of hypertension.
    Eur Heart J. 2023 Oct 27:ehad704. doi: 10.1093.
    >> Share

    September 2023
  27. LIU JN, Zhao ZG, Luo FM
    Pulmonary hypertension-related dynamic left ventricular outflow tract obstruction.
    Eur Heart J. 2023 Sep 19:ehad605. doi: 10.1093.
    >> Share

  28. LIUZZO G, Volpe M
    Silencing liver angiotensinogen synthesis as a novel approach to hypertension management: promises and challenges.
    Eur Heart J. 2023 Sep 8:ehad593. doi: 10.1093.
    >> Share

    August 2023
  29. KARIA N, Howard L, Johnson M, Kiely DG, et al
    Predictors of outcomes in mild pulmonary hypertension according to 2022 ESC/ERS Guidelines: the EVIDENCE-PAH UK study.
    Eur Heart J. 2023 Aug 24:ehad532. doi: 10.1093.
    >> Share

  30. RAO S, Nazarzadeh M, Canoy D, Li Y, et al
    Sodium-based paracetamol: impact on blood pressure, cardiovascular events, and all-cause mortality.
    Eur Heart J. 2023 Aug 23:ehad535. doi: 10.1093.
    >> Share

  31. ZHENG X, Cao J, Zhang G
    Stunning tornado: severe pulmonary hypertension due to cor triatriatum sinister.
    Eur Heart J. 2023 Aug 9:ehad505. doi: 10.1093.
    >> Share

  32. LIUZZO G, Volpe M
    24 Hour blood pressure monitoring is a better predictor of mortality than clinic blood pressure in a large cohort of primary care patients: what is the impact on clinical practice?
    Eur Heart J. 2023;44:2802-2804.
    >> Share

  33. CREA F
    Focus on translational vascular biology: new therapeutic targets in hypertension, aortic aneurysm, and atherosclerosis.
    Eur Heart J. 2023;44:2645-2649.
    >> Share

    July 2023
  34. LANG IM, Andreassen AK, Andersen A, Bouvaist H, et al
    Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a clinical consensus statement of the ESC working group on pulmonary circulation and right ventricular function.
    Eur Heart J. 2023 Jul 20:ehad413. doi: 10.1093.
    >> Share

    June 2023
  35. LU X, Wen P, Xing Q
    Hypertension secondary to renal hypoplasia in a child.
    Eur Heart J. 2023 Jun 28:ehad409. doi: 10.1093.
    >> Share

  36. ZHUANG T, Lei Y, Chang JJ, Zhou YP, et al
    A2AR-mediated lymphangiogenesis via VEGFR2 signaling prevents salt-sensitive hypertension.
    Eur Heart J. 2023 Jun 28:ehad377. doi: 10.1093.
    >> Share

  37. NOSALSKI R, Guzik TJ
    Skin sodium, lymphatics, and blood pressure: a non-canonical mechanism of salt-sensitive hypertension.
    Eur Heart J. 2023 Jun 28:ehad290. doi: 10.1093.
    >> Share

  38. CREA F
    Focus on the complex relationships among hypertension, dementia, and comorbidities.
    Eur Heart J. 2023;44:2051-2054.
    >> Share

  39. LANG IM, Delcroix M
    Novel acquisitions in chronic thromboembolic pulmonary hypertension.
    Eur Heart J. 2023 Jun 15:ehad314. doi: 10.1093.
    >> Share

  40. MARTENS P, Yu S, Larive B, Borlaug BA, et al
    Iron deficiency in pulmonary vascular disease: pathophysiological and clinical implications.
    Eur Heart J. 2023;44:1979-1991.
    >> Share


  41. Correction to: Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI).
    Eur Heart J. 2023 Jun 7:ehad321. doi: 10.1093.
    >> Share

    May 2023
  42. PITT B, Bakris GL
    Resistant hypertension: cardiorenal protection with mineralocorticoid receptor blockade.
    Eur Heart J. 2023 May 24:ehad299. doi: 10.1093.
    >> Share

  43. RAM CVS
    'Normal' blood pressure is no longer a safe haven: take shelter under 'optimal' blood pressure.
    Eur Heart J. 2023;44:1674-1675.
    >> Share

  44. JUSTIN PAUL G, Anne Princy S, Anju S, Anita S, et al
    Pregnancy outcomes in women with heart disease: the Madras Medical College Pregnancy And Cardiac (M-PAC) Registry from India.
    Eur Heart J. 2023;44:1530-1540.
    >> Share

    April 2023
  45. ELHAKEEM A, Taylor AE, Inskip HM, Huang JY, et al
    Long-term cardiometabolic health in people born after assisted reproductive technology: a multi-cohort analysis.
    Eur Heart J. 2023;44:1464-1473.
    >> Share

  46. CREA F
    Focus issue on vascular biology and medicine spanning from management of stroke to new therapeutic targets in aortic dissection and pulmonary hypertension.
    Eur Heart J. 2023;44:1193-1196.
    >> Share

    March 2023
  47. SCHIFFRIN EL, Engert JC
    Hypertension, brain imaging phenotypes, and cognitive impairment: lessons from Mendelian randomization.
    Eur Heart J. 2023 Mar 30:ehad187. doi: 10.1093.
    >> Share

  48. SIEDLINSKI M, Carnevale L, Xu X, Carnevale D, et al
    Genetic analyses identify brain structures related to cognitive impairment associated with elevated blood pressure.
    Eur Heart J. 2023 Mar 27:ehad101. doi: 10.1093.
    >> Share

    February 2023

  49. Corrigendum to: 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respi
    Eur Heart J. 2023 Feb 23:ehad005. doi: 10.1093.
    >> Share

  50. VOLPE M, Gallo G, Rubattu S
    Endocrine functions of the heart: from bench to bedside.
    Eur Heart J. 2023;44:643-655.
    >> Share

  51. VISWANATHAN G, Rajagopal S
    De novo purine synthesis: a new target in pulmonary arterial hypertension?
    Eur Heart J. 2023 Feb 20:ehad078. doi: 10.1093.
    >> Share

  52. BARBATO E, Azizi M, Schmieder RE, Lauder L, et al
    Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI).
    Eur Heart J. 2023 Feb 15:ehad054. doi: 10.1093.
    >> Share

  53. VOLPE M, Liuzzo G
    The 'cold case' of chlortalidone vs. hydrochlorothiazide in hypertension closed by the diuretic comparison project?
    Eur Heart J. 2023 Feb 14:ehad077. doi: 10.1093.
    >> Share

  54. ROSENKRANZ S, Delcroix M, Giannakoulas G, Hoeper MM, et al
    The 'Ten Commandments' of the 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.
    Eur Heart J. 2023 Feb 1:ehad018. doi: 10.1093.
    >> Share

    January 2023
  55. MA Q, Yang Q, Xu J, Sellers HG, et al
    Purine synthesis suppression reduces the development and progression of pulmonary hypertension in rodent models.
    Eur Heart J. 2023 Jan 31:ehad044. doi: 10.1093.
    >> Share

    December 2022
  56. PETERS R, Xu Y, Fitzgerald O, Aung HL, et al
    Blood pressure lowering and prevention of dementia: an individual patient data meta-analysis.
    Eur Heart J. 2022;43:4980-4990.
    >> Share

  57. VOLPE M, Patrono C
    The promise of selective aldosterone synthase inhibition for the management of resistant hypertension.
    Eur Heart J. 2022 Dec 20:ehac754. doi: 10.1093.
    >> Share

  58. CREA F
    Physical exercise, inflammation, and hypertension: how to improve cardiovascular prevention.
    Eur Heart J. 2022;43:4763-4766.
    >> Share

  59. O'SULLIVAN JW, Ashley EA, Elliott PM
    Polygenic risk scores for the prediction of cardiometabolic disease.
    Eur Heart J. 2022 Dec 7:ehac648. doi: 10.1093.
    >> Share

    November 2022
  60. HAXHA S, Halili A, Malmborg M, Pedersen-Bjergaard U, et al
    Type 2 diabetes mellitus and higher rate of complete atrioventricular block: a Danish Nationwide Registry.
    Eur Heart J. 2022 Nov 26:ehac662. doi: 10.1093.
    >> Share

  61. LAUDER L, Mahfoud F, Azizi M, Bhatt DL, et al
    Hypertension management in patients with cardiovascular comorbidities.
    Eur Heart J. 2022 Nov 7. pii: 6808663. doi: 10.1093.
    >> Share

  62. SCHUTTE AE
    The promise and pitfalls of novel cuffless blood pressure devices.
    Eur Heart J. 2022;43:4222-4223.
    >> Share

    October 2022
  63. CREA F
    Update on a silent killer: arterial hypertension.
    Eur Heart J. 2022;43:3595-3598.
    >> Share

  64. RIVASI G, Groppelli A, Brignole M, Soranna D, et al
    Association between hypotension during 24 h ambulatory blood pressure monitoring and reflex syncope: the SynABPM 1 study.
    Eur Heart J. 2022;43:3765-3776.
    >> Share

    September 2022
  65. GERDTS E, Sudano I, Brouwers S, Borghi C, et al
    Sex differences in arterial hypertension.
    Eur Heart J. 2022 Sep 22. pii: 6711154. doi: 10.1093.
    >> Share

  66. CREA F
    Hypertension in children, adolescents, and pregnant women: challenges and opportunities.
    Eur Heart J. 2022;43:3275-3278.
    >> Share

  67. WHELTON PK, Carey RM, Mancia G, Kreutz R, et al
    Harmonization of the American College of Cardiology/American Heart Association and European Society of Cardiology/European Society of Hypertension Blood Pressure/Hypertension Guidelines.
    Eur Heart J. 2022;43:3302-3311.
    >> Share

    August 2022
  68. HUMBERT M, Kovacs G, Hoeper MM, Badagliacca R, et al
    2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.
    Eur Heart J. 2022 Aug 26. pii: 6673929. doi: 10.1093.
    >> Share

  69. WENZEL P
    Thromboinflammation in cardiovascular disease: lessons learned for the management of hypertension, heart failure, and aortic valve stenosis.
    Eur Heart J. 2022 Aug 18. pii: 6671020. doi: 10.1093.
    >> Share

  70. PANDEY AK, Bhatt DL, Cosentino F, Marx N, et al
    Non-steroidal mineralocorticoid receptor antagonists in cardiorenal disease.
    Eur Heart J. 2022;43:2931-2945.
    >> Share

  71. UMEI TC, Kishino Y, Kawakami T, Fukuda K, et al
    Recurrent pulmonary thrombosis after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension.
    Eur Heart J. 2022 Aug 8. pii: 6658235. doi: 10.1093.
    >> Share

  72. WOUDA RD, Boekholdt SM, Khaw KT, Wareham NJ, et al
    Sex-specific associations between potassium intake, blood pressure, and cardiovascular outcomes: the EPIC-Norfolk study.
    Eur Heart J. 2022;43:2867-2875.
    >> Share

  73. JOSEPH P, Kutty VR, Mohan V, Kumar R, et al
    Cardiovascular disease, mortality, and their associations with modifiable risk factors in a multi-national South Asia cohort: a PURE substudy.
    Eur Heart J. 2022;43:2831-2840.
    >> Share

  74. LI S, Liu Z, Joseph P, Hu B, et al
    Modifiable risk factors associated with cardiovascular disease and mortality in China: a PURE substudy.
    Eur Heart J. 2022;43:2852-2863.
    >> Share

  75. PRESCOTT E
    Lessons from PURE on modifiable risk.
    Eur Heart J. 2022;43:2864-2866.
    >> Share

  76. LOPEZ-JARAMILLO P, Joseph P, Lopez-Lopez JP, Lanas F, et al
    Risk factors, cardiovascular disease, and mortality in South America: a PURE substudy.
    Eur Heart J. 2022;43:2841-2851.
    >> Share

  77. CAULDWELL M
    Understanding the implications of hypertensive disorders in pregnancy in women with heart disease.
    Eur Heart J. 2022 Aug 3. pii: 6653698. doi: 10.1093.
    >> Share

  78. DACHS TM, Duca F, Rettl R, Binder-Rodriguez C, et al
    Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trial.
    Eur Heart J. 2022 Aug 1. pii: 6652608. doi: 10.1093.
    >> Share

  79. BAUERSACHS J, Olsson KM
    Targeting pulmonary hypertension in patients with heart failure and preserved ejection fraction: rather static than DYNAMIC development?
    Eur Heart J. 2022 Aug 1. pii: 6652609. doi: 10.1093.
    >> Share

    July 2022
  80. DE SIMONE G, Mancusi C, Hanssen H, Genovesi S, et al
    Hypertension in children and adolescents.
    Eur Heart J. 2022 Jul 27. pii: 6633855. doi: 10.1093.
    >> Share

  81. TADIC M, Cuspidi C, Marwick TH
    Phenotyping the hypertensive heart.
    Eur Heart J. 2022 Jul 23. pii: 6648534. doi: 10.1093.
    >> Share

  82. VERGALLO R, Volpe M
    Long lasting effects of renal denervation: lights and shadows of the SPYRAL HTN-ON MED 3-year follow-up.
    Eur Heart J. 2022;43:2655-2656.
    >> Share

  83. OMOTE K, Sorimachi H, Obokata M, Reddy YNV, et al
    Pulmonary vascular disease in pulmonary hypertension due to left heart disease: pathophysiologic implications.
    Eur Heart J. 2022 Jul 7. pii: 6633254. doi: 10.1093.
    >> Share

  84. HOEPER MM, Rosenkranz S
    Was Paul Wood wrong about pre-capillary pulmonary hypertension protecting against pulmonary congestion in left heart disease?
    Eur Heart J. 2022 Jul 7. pii: 6633248. doi: 10.1093.
    >> Share

    June 2022
  85. RAMLAKHAN KP, Malhame I, Marelli A, Rutz T, et al
    Hypertensive disorders of pregnant women with heart disease: the ESC EORP ROPAC Registry.
    Eur Heart J. 2022 Jun 21. pii: 6612238. doi: 10.1093.
    >> Share

    May 2022
  86. LUCAS-HERALD AK, Montezano AC, Alves-Lopes R, Haddow L, et al
    Vascular dysfunction and increased cardiovascular risk in hypospadias.
    Eur Heart J. 2022;43:1832-1845.
    >> Share

  87. GALIUTO L, Volpe M
    Treatment of mild hypertension improves pregnancy outcomes.
    Eur Heart J. 2022 May 13. pii: 6585107. doi: 10.1093.
    >> Share

  88. SCHUTTE AE, Neal B
    The sodium hidden in medication: a tough pill to swallow.
    Eur Heart J. 2022;43:1756-1758.
    >> Share

    April 2022
  89. VALERIO L, Mavromanoli AC, Barco S, Abele C, et al
    Chronic thromboembolic pulmonary hypertension and impairment after pulmonary embolism: the FOCUS study.
    Eur Heart J. 2022 Apr 28. pii: 6575686. doi: 10.1093.
    >> Share

  90. OJJI D, Aifah A, Dulli L, Iwelunmor J, et al
    Early stakeholder engagement lessons from managing hypertension among people living with human-immunodeficiency virus: an integrated model (MAP-IT).
    Eur Heart J. 2022 Apr 20. pii: 6571044. doi: 10.1093.
    >> Share

    March 2022
  91. VOLPE M, Patrono C
    Blood pressure lowering drugs differ in their capacity to prevent type 2 diabetes.
    Eur Heart J. 2022;43:1189-1190.
    >> Share

    February 2022
  92. ZENG C, Rosenberg L, Li X, Djousse L, et al
    Sodium-containing acetaminophen and cardiovascular outcomes in individuals with and without hypertension.
    Eur Heart J. 2022 Feb 24. pii: 6535634. doi: 10.1093.
    >> Share

  93. RAM CVS
    Renal denervation therapy for hypertension: all that glitters is not gold.
    Eur Heart J. 2022 Feb 15. pii: 6529363. doi: 10.1093.
    >> Share

  94. VOLPE M, Patrono C
    Age-independent benefits of blood pressure lowering: are they applicable to all patients?
    Eur Heart J. 2022;43:448-449.
    >> Share

  95. MESSERLI FH, Siontis GCM, Bavishi C, Messerli AW, et al
    Importance of pulse pressure at low systolic blood pressure.
    Eur Heart J. 2022;43:540.
    >> Share

  96. SPENCE JD, Muller LO, Blanco PJ
    How to identify which patients should not have a systolic blood pressure target of <120 mmHg.
    Eur Heart J. 2022;43:538-539.
    >> Share

  97. CORRAO G, Mancia G
    Research strategies in treatment of hypertension: value of retrospective real-life data.
    Eur Heart J. 2022 Feb 3. pii: 6520830. doi: 10.1093.
    >> Share

    December 2021
  98. VOLPE M, Patrono C
    Quadruple combination of quarter doses of blood pressure-lowering agents: a string QUARTET in the symphony of hypertension management?
    Eur Heart J. 2021;42:4885-4886.
    >> Share

  99. VOLPE M, Patrono C
    Another STEP towards tighter control of blood pressure in the elderly.
    Eur Heart J. 2021;42:4715-4716.
    >> Share

    October 2021
  100. MIHAILIDOU AS, Gulati M
    Impact of hypertensive disorders of pregnancy: lessons from CONCEPTION.
    Eur Heart J. 2021 Oct 18. pii: 6399973. doi: 10.1093.
    >> Share

  101. BOUCHERON P, Lailler G, Moutengou E, Regnault N, et al
    Hypertensive disorders of pregnancy and onset of chronic hypertension in France: the nationwide CONCEPTION study.
    Eur Heart J. 2021 Oct 13. pii: 6395270. doi: 10.1093.
    >> Share

    September 2021
  102. RUILOPE LM, Valenzuela PL, Lucia A
    Digital therapeutics and lifestyle: the start of a new era in the management of arterial hypertension?
    Eur Heart J. 2021 Sep 27. pii: 6377082. doi: 10.1093.
    >> Share

  103. CREA F
    The ESC Guidelines on heart failure, sacubitril-valsartan in resistant hypertension, and new therapeutic targets in myocardial hypertrophy.
    Eur Heart J. 2021;42:3581-3585.
    >> Share

  104. FUKUMOTO Y
    Takayasu arteritis-associated pulmonary hypertension.
    Eur Heart J. 2021 Sep 20. pii: 6372800. doi: 10.1093.
    >> Share

  105. LINZ D, Gawalko M, Sanders P, Penders J, et al
    Does gut microbiota affect atrial rhythm? Causalities and speculations.
    Eur Heart J. 2021;42:3521-3525.
    >> Share

  106. BAYES-GENIS A, Diez J
    Transition to heart failure in hypertension: going to the heart of the matter.
    Eur Heart J. 2021 Sep 13. pii: 6369562. doi: 10.1093.
    >> Share

  107. JIANG X, Zhu YJ, Zhou YP, Peng FH, et al
    Clinical features and survival in Takayasu's arteritis-associated pulmonary hypertension: a nationwide study.
    Eur Heart J. 2021 Sep 10. pii: 6368314. doi: 10.1093.
    >> Share

  108. BROWN JM, Zhou W, Weber B, Divakaran S, et al
    Low coronary flow relative to myocardial mass predicts heart failure in symptomatic hypertensive patients with no obstructive coronary artery disease.
    Eur Heart J. 2021 Sep 7. pii: 6365821. doi: 10.1093.
    >> Share

  109. MESSERLI FH, Bavishi C, Messerli AW, Siontis GCM, et al
    Cerebrotoxicity of antihypertensive therapy in the UK Biobank Cohort Study.
    Eur Heart J. 2021 Sep 4. pii: 6364086. doi: 10.1093.
    >> Share

    August 2021
  110. KARIO K, Nomura A, Harada N, Okura A, et al
    Efficacy of a digital therapeutics system in the management of essential hypertension: the HERB-DH1 pivotal trial.
    Eur Heart J. 2021 Aug 29. pii: 6358480. doi: 10.1093.
    >> Share

  111. VOLPE M, Gallo G
    Sacubitril/valsartan for heart failure with preserved ejection fraction and resistant hypertension: one shot for a double strike?
    Eur Heart J. 2021 Aug 15. pii: 6352588. doi: 10.1093.
    >> Share

  112. JACKSON AM, Jhund PS, Anand IS, Dungen HD, et al
    Sacubitril-valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction.
    Eur Heart J. 2021 Aug 15. pii: 6352587. doi: 10.1093.
    >> Share

    July 2021
  113. VOLPE M, Patrono C
    The key role of blood pressure lowering in cardiovascular prevention irrespective of baseline blood pressure and risk profile.
    Eur Heart J. 2021;42:2814-2815.
    >> Share

    June 2021
  114. VOLPE M, Patrono C
    A SPRINT towards tighter control of blood pressure in hypertension.
    Eur Heart J. 2021 Jun 25. pii: 6309731. doi: 10.1093.
    >> Share

  115. HE FJ, Campbell NRC, Woodward M, MacGregor GA, et al
    Salt reduction to prevent hypertension: the reasons of the controversy.
    Eur Heart J. 2021 Jun 12. pii: 6297147. doi: 10.1093.
    >> Share

  116. MESSERLI FH, Brguljan J, Rexhaj E, Sever P, et al
    Lowering systolic blood pressure to 120 mmHg or The Lancet's true grit.
    Eur Heart J. 2021;42:2052-2059.
    >> Share

  117. YAN Y, Mu J
    Salt intake paradox: the estimation method matters.
    Eur Heart J. 2021;42:2133.
    >> Share

    May 2021
  118. LANDMESSER U, Lehmann I, Eils R
    Hyperinflammation as underlying mechanism predisposing patients with cardiovascular diseases for severe COVID-19.
    Eur Heart J. 2021;42:1720-1721.
    >> Share

    April 2021

  119. Erratum to: A cohort study and meta-analysis of isolated diastolic hypertension: searching for a threshold to guide treatment.
    Eur Heart J. 2021 Apr 13. pii: 6224359. doi: 10.1093.
    >> Share

    March 2021
  120. VAN DIEPEN S, Armstrong PW
    Learning whether to subtract beta-blockers: it's about time.
    Eur Heart J. 2021;42:915-918.
    >> Share

    February 2021
  121. ESTRUCH R, Ruilope LM, Cosentino F
    The year in cardiovascular medicine 2020: epidemiology and prevention.
    Eur Heart J. 2021;42:813-821.
    >> Share

  122. WARTOLOWSKA KA, Webb AJS
    Midlife blood pressure is associated with the severity of white matter hyperintensities: analysis of the UK Biobank cohort study.
    Eur Heart J. 2021;42:750-757.
    >> Share

    November 2020
  123. LIEW CH, McEvoy JW
    The diastolic blood pressure J-curve remains an observational research phenomenon that has not yet been proven as causal and should not be used to make invasive treatment decisions.
    Eur Heart J. 2020;41:4284-4285.
    >> Share

  124. VOLPE M, Patrono C
    Decline in blood pressure control trends in the US: a real step back: Comment on National Health and Nutrition Examination Survey (NHANES) data.
    Eur Heart J. 2020;41:3986-3987.
    >> Share

    March 2020
  125. BOHM M, Ferreira JP, Mahfoud F, Duarte K, et al
    Myocardial reperfusion reverses the J-curve association of cardiovascular risk and diastolic blood pressure in patients with left ventricular dysfunction and heart failure after myocardial infarction: insights from the EPHESUS trial.
    Eur Heart J. 2020 Mar 2. pii: 5771273. doi: 10.1093.
    >> Share

    May 2019
  126. SHARASHOVA E, Wilsgaard T, Ball J, Morseth B, et al
    Long-term blood pressure trajectories and incident atrial fibrillation in women and men: the Tromso Study.
    Eur Heart J. 2019 May 3. pii: 5485289. doi: 10.1093.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016